GSA Capital Partners »

Kinnate Biopharma shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $803k 339k 2.37
2023-09-30 $524k 374k 1.40
2023-06-30 $728k 240k 3.03
2023-03-31 $232k 37k 6.25
2022-12-31 $428k 70k 6.10
2022-09-30 $876k 73k 11.95
2022-06-30 $711k 56k 12.61
2022-03-31 $531k 47k 11.26